IMAGE 2021
June 8, 2021
No Comments
This is the 8th IMAGE conference, which focuses on differences in sexual development, and puberty disorders and reproductive problems in adolescents and young adults.
Topic: Growth disorders
Scoliosis risk in PWS independent of growth hormone treatment
May 27, 2021
No Comments
A long-term follow-up study of children with Prader-Willi syndrome has found no evidence to indicate that growth hormone therapy affects the risk or severity of scoliosis in this population.
Knowledge gaps make teens with endocrine disorders unready for transition to adult clinic
April 27, 2021
No Comments
Researchers find that teenagers with endocrine disorders often have gaps in their knowledge of their condition and how to manage it, making them poorly prepared for transition to adult clinic.
Polygenic risk score rivals mid-parental height for predicting adult short stature
April 27, 2021
No Comments
A polygenic risk score for height can predict a child’s adult height with similar accuracy to their mid-parental height, say researchers.
Endocrinopathy risk highlighted among childhood brain tumour survivors
March 30, 2021
No Comments
Around 70% of children who survive a brain tumour develop at least one form of endocrine dysfunction, suggests a long-term study of patients attending a hospital in Portugal.
BMI link to earlier puberty onset in boys confirmed
March 1, 2021
No Comments
Longitudinal study findings support a relationship between body mass index and the timing of puberty in boys, with a link found between obesity and precocious gonadarche.
Collagenopathy may underlie some familial short stature cases without clear dysplasia
March 1, 2021
No Comments
Collagenopathies could account for around one in 10 cases of familial short stature even when there are no obvious signs of dysplasia, say researchers.
GH therapy can bring Noonan syndrome children’s height within population norms
February 1, 2021
No Comments
A study of children with Noonan syndrome treated in clinical practice shows a good response to growth hormone treatment, with the majority achieving a height within population norms.
GnRHa increases adult height, reduces BMI for precocious puberty girls
February 1, 2021
No Comments
A systematic review and meta-analysis suggests that girls with idiopathic central precious puberty who are treated with gonadotropin-releasing hormone analogue therapy may expect to have a higher final adult height and lower BMI than if they do not receive the treatment.
Abnormal growth ‘evolves years’ before juvenile acquired hypothyroidism diagnosis
December 18, 2020
No Comments
A longitudinal study of Finnish patients with juvenile acquired hypothyroidism has revealed that an abnormal growth pattern may be present for up to 5 years before diagnosis.
